Related Experiment Video
Updated: May 19, 2026

An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides
Published on: November 29, 2016
Sox2 acts through Sox21 to regulate transcription in pluripotent and differentiated cells
Andrey N Kuzmichev1, Suel-Kee Kim, Ana C D'Alessio
1Laboratory of Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Sox2 is an important transcriptional regulator in embryonic and adult stem cells. Recently, Sox2 was identified as an oncogene in many endodermal cancers, including colon cancer. There is great interest in how Sox2 cooperates with other transcription factors to regulate stem cell renewal, differentiation, and reprogramming. However, we still lack a general understanding of Sox2 transcriptional action. To determine transcriptional partners of Sox2 in adult cells, we generated mice where gene expression could be induced by an externally applied stimulus. We analyzed the consequences in the intestine where cell turnover is rapid. Sox2 expression, but not Oct4, specifically increased the numbers of stem cells and repressed Cdx2, a master regulator of endodermal identity. In vivo studies demonstrated that Sox21, another member of the SoxB gene family, was a specific, immediate, and cell-autonomous target of Sox2 in intestinal stem cells. In vitro experiments showed that Sox21 was sufficient to repress Cdx2 in colon cancer cells and in pluripotent stem cells. Sox21 was also specifically induced by Sox2 in fibroblasts and inhibition of Sox21 blocked reprogramming to the pluripotent state. These results show that transcriptional induction of Sox21 is a rapid and general mediator of the effects of Sox2 on cell identity in a wide range of cell types.
Insights
Sox2 (Sex-determining region Y-box 2) rapidly induces Sox21, a key factor in regulating cell identity. This mechanism impacts stem cell renewal, differentiation, and reprogramming across various cell types, including in colon cancer.
Area of Science:
- Stem cell biology
- Transcriptional regulation
- Cancer research
Background:
- Sox2 is a crucial transcriptional regulator in stem cells and an oncogene in endodermal cancers.
- Understanding Sox2's cooperative transcriptional action is vital for stem cell renewal, differentiation, and reprogramming.
- A general understanding of Sox2's transcriptional mechanisms is currently lacking.
Purpose of the Study:
- To identify transcriptional partners of Sox2 in adult cells.
- To elucidate the role of Sox2 in intestinal stem cell regulation.
- To investigate the mechanism by which Sox2 influences cell identity.
Main Methods:
- Generation of inducible mouse models for studying Sox2 gene expression.
- In vivo analysis of Sox2 effects in the rapidly self-renewing intestinal epithelium.
- In vitro experiments using colon cancer cells and pluripotent stem cells.
Main Results:
- Sox2 expression increased intestinal stem cell numbers and repressed Cdx2, a key regulator of endodermal identity.
- Sox21 was identified as a specific, immediate, and cell-autonomous target of Sox2 in intestinal stem cells.
- Sox21 repressed Cdx2 in colon cancer and pluripotent stem cells, and its induction by Sox2 in fibroblasts was necessary for reprogramming.
Conclusions:
- Transcriptional induction of Sox21 is a rapid and general mediator of Sox2's effects on cell identity.
- Sox2 influences cell fate through the induction of Sox21 in diverse cell types.
- This study reveals a novel mechanism for Sox2-mediated regulation of cell identity and reprogramming.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Somatic to iPS Cell Reprogramming
Pleiotropy
Maintenance of the ES Cell State
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

